A phase I/II, partially randomised, open-labelled study of visilizumab in patients with severe ulcerative colitis refractory to intravenous corticosteroids

Update Il y a 4 ans
Reference: ISRCTN94152325

Woman and Man

Extract

Not provided at time of registration


Inclusion criteria

  • Ulcerative colitis


Links